Search

everythinglearnresearchcommunity

for

Search:↓

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

DHT, a testosterone byproduct, causes male pattern baldness.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

Oxidative stress contributes to hair graying and loss as we age.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Platelet-rich plasma (PRP) injections can effectively increase hair density and thickness in people with androgenic alopecia, without major side effects.

Platelet Rich Plasma (PRP) injections can improve hair count, thickness, and strength in people with androgenic alopecia.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Sebocytes play a key role in controlling androgen levels in human skin.

Gene mutations can cause problems in male genital development.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.